Contributors
Ken Farabaugh

Ken Farabaugh is the ASBMB’s science editor.
Articles by Ken Farabaugh

Journal News
From the journals: JBC
May 10, 2023
A translation priority “bar code.” Novel protein cleavage in a cerebral disease. A key molecule in lipid droplet catabolism. Read about recent papers on these topics.

Journal News
From the journals: JBC
March 17, 2023
With sulfur, life finds a way. Specific anti-cancer antibodies. Exercise-induced signaling cross talk. Read about recent articles on these topics.

Journal News
Unlocking drug resistance in pancreatic cancer
Feb. 21, 2023
Discovering key metabolic regulators of multiple pathways of acquired drug resistance in pancreatic cancer could lead to new treatment strategies.

Journal News
From the journals: JBC
Feb. 17, 2023
Hijacking chaperones for iron. A new cause of male infertility. Novel regulation of a ribosomal factor. Read about papers on these topics recently published in the Journal of Biological Chemistry.

Journal News
From the journals: JBC
Feb. 8, 2023
The timing of lipid metabolism. Modifying actin assembly dynamics. How Lyme disease evades the immune system. Read about these recent papers in the Journal of Biological Chemistry.

Annual Meeting
Engelking seeks to balance research and medicine
Jan. 19, 2023
Luke Engelking, a Journal of Lipid Research junior associate editor, will discuss his work during the JLR Spotlight Session at Discover BMB 2023.

Journal News
From the journals: JBC
Jan. 5, 2023
A combined strategy to fight cancer growth. Polymorphisms dictate prion pathogenesis. An oxidative switch of chaperone activity. Read about papers on these topics published recently in the Journal of Biological Chemistry.

Journal News
From the journals: JBC
Nov. 18, 2022
Exciting peptide drugs for heart disease. RNA sensing of basic pH. Biased hormonal signaling. Read about papers on these topics recently published in the Journal of Biological Chemistry.

Journal News
Preventing missed diagnoses of hyperekplexia
Nov. 3, 2022
Researchers say screening for newly identified genetic mutation and others could disambiguate the condition from epilepsy and reduce unnecessary antiepileptic therapies.